Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
By slowing down stomach emptying, it helps you feel fuller for longer, reducing the urge to overeat
Potential disruption may emerge from companies like Roche, which is developing an oral GLP-1/GIP dual agonist and could enter the market in the post-hype cycle with a lower-cost alternative
Currently, several obesity companies, such as YSOPIA Bioscience, Innovent Biologics, Glaceum, Shionogi, Aardvark Therapeutics, NuSirt Biopharma, Novartis,, and others, across the globe are developing obesity therapies
Bile is released in response to eating foods containing fat and then emulsifies that fat for absorption by the intestines
US$ 22.58
US$ 29.76
US$ 23.36
